2018-04-03 17:50:08 UTC

A Clinician’s Guide to FMT

About

These slides were presented as part of the 2018 Crohn’s and Colitis Congress pre-workshop on fecal microbiota transplantation (FMT). The slides cover the current state of evidence on the safety, efficacy and administration of FMT to treat IBD, C. difficile infection and other related conditions for both adult and pediatric populations. The current U.S. regulatory framework for FMT is also addressed.

Diagnosing Recurrent Clostridium difficile Infection (rCDI) — Testing Strategies, Pitfalls and Differentiating rCDI from Post Infectious IBS
Dina Kao, MD, FRCPC
University of Alberta

Download PDF
 

C. difficile Infection in IBD Patients and Current Status of FMT in this Population
Alexander Khoruts, MD
University of Minnesota Microbiota Therapeutics Program

Download PDF
 

Managing FMT Non-Responders and Adverse Events
Monika Fischer, MD, MSc.
Associate Professor
Indiana University, Indiana, USA

Download PDF
 

Regulatory Considerations for Fecal Microbiota Transplant
Diane E. Hoffmann, MS, JD
Professor of Law and Director, Law & Health Care Program
University of Maryland Francis King Carey School of Law

Download PDF
 

Fecal Microbiota Transplant for Crohn’s Disease, Ulcerative Colitis and Pouchitis
Najwa El-Nachef, MD
University of California, San Francisco

Download PDF
 

FMT for Recurrent C. difficile Infection and IBD in the Pediatric Population
Maria Oliva-Hemker, MD
Johns Hopkins University School of Medicine

Download PDF
 

FMT on the Horizon: Metabolic Syndrome and Other Diseases
Max Nieuwdorp, MD, PhD
Internist-endocrinologist
Chair Amsterdam Diabetes Center

Download PDF